Effect of a Multidisciplinary Intervention on Fatigue in Lymphoma Survivors With Persistent Fatigue: A Randomized Controlled Trial (the REFUEL trial)
Journal of Clinical Oncology · 20.11.2026
DOI: 10.1200/jco-26-00414 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Oncology, online erschienen am 20.11.2026. Verfasst von Synne-Kristin H. Bøhn und 25 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Purpose
Persistent fatigue is a prevalent, complex, and distressing late effect among lymphoma survivors. We examined the effect of a multidisciplinary intervention on fatigue among lymphoma survivors with persistent fatigue.
Methods
Lymphoma survivors with persistent fatigue (moderate to severe fatigue ≥6 months) were randomly assigned to usual care (n = 75) or a 12-week multidisciplinary intervention (n = 75). The intervention consisted of patient education, physical exercise, a cognitive-behavioral therapy–based program, and nutritional counseling. Total fatigue was assessed by the Chalder Fatigue Questionnaire (range, 0-33) 3 months after random assignment (T1; primary outcome) and at 6 (T2) and 9 (T3) months after random assignment (secondary outcomes). Other secondary outcomes were functioning and global health status/quality of life (QoL) assessed by European Organisation for Research and Treatment of Cancer QoL Questionnaire-C30. Effects were analyzed with baseline-adjusted linear mixed models for repeated measures.
Results
Compared with usual care, the intervention group reported significantly lower total fatigue at T1 (between-group difference [BGD], –3.5 [95% CI, –5.4 to –1.6]; P < .001). Secondary outcome analyses indicated that total fatigue remained lower in the intervention group at T2 (BGD, –2.4 [95% CI, –4.4 to –0.5]), but not at T3 (BGD, –0.9 [95% CI, –3.0 to 1.2]). At T1, secondary outcome analyses indicated positive intervention effects on physical (BGD, 3.8 [95% CI, 0.2 to 7.3]) and role functioning (BGD, 9.2 [95% CI, 0.9 to 17.5]) and global health status/QoL (BGD, 9.5 [95% CI, 3.5 to 15.4]), but not on social (BGD, –0.1 [95% CI, –7.4 to 7.3]), emotional (BGD, 5.6 [95% CI, 0.0 to 11.3]), or cognitive functioning (BGD, 3.5 [95% CI, –3.3 to 10.2]).
Conclusion
A multidisciplinary intervention improved fatigue among lymphoma survivors with persistent fatigue. The effect appeared to be maintained 6 months after random assignment but dissipated at 9 months.
Zitieren
APA
Bøhn, S. H., Skaali, T., Wisløff, T., Kiserud, C. E., Fosså, A., Seland, M., Fagerli, U., Reinertsen, K. V., Blomhoff, R., Courneya, K. S., Edvardsen, E., Gjerset, G. M., Henriksen, H. B., Lie, H. C., Loge, J. H., Nilsen, T. S., Oldervoll, L. M., Raastad, T., Rueegg, C. S., …, & Thorsen, L. (2026). Effect of a Multidisciplinary Intervention on Fatigue in Lymphoma Survivors With Persistent Fatigue: A Randomized Controlled Trial (the REFUEL trial). Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-00414
Vancouver
Bøhn SH, Skaali T, Wisløff T, Kiserud CE, Fosså A, Seland M, et al. Effect of a Multidisciplinary Intervention on Fatigue in Lymphoma Survivors With Persistent Fatigue: A Randomized Controlled Trial (the REFUEL trial). Journal of Clinical Oncology. 2026. doi:10.1200/jco-26-00414
BibTeX
@article{Bhn2026,
author = {Bøhn, Synne-Kristin H. and Skaali, Tone and Wisløff, Torbjørn and Kiserud, Cecilie E. and Fosså, Alexander and Seland, Mette and Fagerli, Unn-Merete and Reinertsen, Kristin V. and Blomhoff, Rune and Courneya, Kerry S. and Edvardsen, Elisabeth and Gjerset, Gunhild M. and Henriksen, Hege B. and Lie, Hanne C. and Loge, Jon Håvard and Nilsen, Tormod S. and Oldervoll, Line Merethe and Raastad, Truls and Rueegg, Corina S. and Rutkovskiy, Arkady and Berge, Torkil and Fjerstad, Elin and Sandberg, Gro and Slott, Malene and Viktil, Linn and Thorsen, Lene},
title = {Effect of a Multidisciplinary Intervention on Fatigue in Lymphoma Survivors With Persistent Fatigue: A Randomized Controlled Trial (the REFUEL trial)},
journal = {Journal of Clinical Oncology},
year = {2026},
doi = {10.1200/jco-26-00414}
}
EUVIMED